Literature DB >> 27338613

Pure Autonomic Failure.

Pariwat Thaisetthawatkul1.   

Abstract

Pure autonomic failure (PAF) is a rare sporadic neurodegenerative autonomic disorder characterized by slowly progressive pan autonomic failure without other features of neurologic dysfunctions. The main clinical symptoms result from neurogenic orthostatic hypotension and urinary and gastrointestinal autonomic dysfunctions. Autonomic failure in PAF is caused by neuronal degeneration of pre- and postganglionic sympathetic and parasympathetic neurons in the thoracic spinal cord and paravertebral autonomic ganglia. The presence of Lewy bodies and α-synuclein deposits in these neural structures suggests that PAF is one of Lewy body synucleinopathies, examples of which include multiple system atrophy, Parkinson disease, and Lewy body disease. There is currently no specific treatment to stop progression in PAF. Management of autonomic symptoms is the mainstay of treatment and includes management of orthostatic hypotension and supine hypertension. The prognosis for survival of PAF is better than for the other synucleinopathies.

Entities:  

Keywords:  Lewy body; Neurogenic orthostatic hypotension; Pure autonomic failure; Synucleinopathy; α-synuclein

Mesh:

Substances:

Year:  2016        PMID: 27338613     DOI: 10.1007/s11910-016-0673-2

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  70 in total

1.  Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy.

Authors:  S Orimo; T Oka; H Miura; K Tsuchiya; F Mori; K Wakabayashi; T Nagao; M Yokochi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

2.  Plasma norepinephrine responses to head-up tilt are misleading in autonomic failure.

Authors:  I T Meredith; G Eisenhofer; G W Lambert; G L Jennings; J Thompson; M D Esler
Journal:  Hypertension       Date:  1992-06       Impact factor: 10.190

3.  Sympathetic denervation of myocardium demonstrated by 123I-MIBG scintigraphy in pure progressive autonomic failure.

Authors:  M Yoshida; Y Fukumoto; Y Kuroda; N Ohkoshi
Journal:  Eur Neurol       Date:  1997       Impact factor: 1.710

4.  Sympathetically mediated hypertension in autonomic failure.

Authors:  J R Shannon; J Jordan; A Diedrich; B Pohar; B K Black; D Robertson; I Biaggioni
Journal:  Circulation       Date:  2000-06-13       Impact factor: 29.690

5.  Norepinephrine precursor therapy in neurogenic orthostatic hypotension.

Authors:  Horacio Kaufmann; Daniela Saadia; Andrei Voustianiouk; David S Goldstein; Courtney Holmes; Melvin D Yahr; Rachel Nardin; Roy Freeman
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

6.  Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure.

Authors:  S Braune; M Reinhardt; J Bathmann; T Krause; M Lehmann; C H Lücking
Journal:  Acta Neurol Scand       Date:  1998-05       Impact factor: 3.209

7.  Olfactory dysfunction in pure autonomic failure: Implications for the pathogenesis of Lewy body diseases.

Authors:  David S Goldstein; LaToya Sewell
Journal:  Parkinsonism Relat Disord       Date:  2009-02-07       Impact factor: 4.891

8.  Skin nerve misfolded α-synuclein in pure autonomic failure and Parkinson disease.

Authors:  Vincenzo Donadio; Alex Incensi; Cristina Piccinini; Pietro Cortelli; Maria Pia Giannoccaro; Agostino Baruzzi; Rocco Liguori
Journal:  Ann Neurol       Date:  2015-12-29       Impact factor: 10.422

9.  α-Synuclein in cutaneous autonomic nerves.

Authors:  Ningshan Wang; Christopher H Gibbons; Jacob Lafo; Roy Freeman
Journal:  Neurology       Date:  2013-10-02       Impact factor: 9.910

Review 10.  Pharmacological treatment of postprandial reductions in blood pressure: a systematic review.

Authors:  Alice C L Ong; Phyo K Myint; John F Potter
Journal:  J Am Geriatr Soc       Date:  2014-03-17       Impact factor: 5.562

View more
  8 in total

1.  Spinal cord involvement in Lewy body-related α-synucleinopathies.

Authors:  Raffaele Nardone; Yvonne Höller; Francesco Brigo; Viviana Versace; Luca Sebastianelli; Cristina Florea; Kerstin Schwenker; Stefan Golaszewski; Leopold Saltuari; Eugen Trinka
Journal:  J Spinal Cord Med       Date:  2019-01-08       Impact factor: 1.985

2.  Cerebrospinal fluid fistula in a patient with chronic constipation related to an autonomic dysfunction and revealed by bacterial meningitis - A case report.

Authors:  Hilal Abboud; Hanane Kharbouch; Yasser Arkha; Mohamed Choukri
Journal:  Surg Neurol Int       Date:  2020-07-18

3.  Autonomic ganglionic injection of α-synuclein fibrils as a model of pure autonomic failure α-synucleinopathy.

Authors:  Xue-Jing Wang; Ming-Ming Ma; Le-Bo Zhou; Xiao-Yi Jiang; Miao-Miao Hao; Robert K F Teng; Erxi Wu; Bei-Sha Tang; Jia-Yi Li; Jun-Fang Teng; Xue-Bing Ding
Journal:  Nat Commun       Date:  2020-02-18       Impact factor: 14.919

Review 4.  The Role of Glial Mitochondria in α-Synuclein Toxicity.

Authors:  Yu-Mi Jeon; Younghwi Kwon; Myungjin Jo; Shinrye Lee; Seyeon Kim; Hyung-Jun Kim
Journal:  Front Cell Dev Biol       Date:  2020-11-11

Review 5.  Passive Immunization in Alpha-Synuclein Preclinical Animal Models.

Authors:  Jonas Folke; Nelson Ferreira; Tomasz Brudek; Per Borghammer; Nathalie Van Den Berge
Journal:  Biomolecules       Date:  2022-01-20

Review 6.  A Focus on the Beneficial Effects of Alpha Synuclein and a Re-Appraisal of Synucleinopathies.

Authors:  Larisa Ryskalin; Carla L Busceti; Fiona Limanaqi; Francesca Biagioni; Stefano Gambardella; Francesco Fornai
Journal:  Curr Protein Pept Sci       Date:  2018       Impact factor: 3.272

7.  Pure Autonomic Failure with Asymptomatic Hypertensive Urgency: A Case Report and Literature Review.

Authors:  Alwaleed Aljohar; Taim Muayqil; Abdulrahman Aldeeri; Anwar Jammah; Ahmad Hersi; Khalid Alhabib
Journal:  Case Rep Neurol       Date:  2018-12-13

8.  Is Ross Syndrome a New Type of Synucleinopathy? A Brief Research Report.

Authors:  Mingming Ma; Jing Yao; Yongkang Chen; Han Liu; Danhao Xia; Haiyan Tian; Xinxin Wang; Erxi Wu; Xuejing Wang; Xuebing Ding
Journal:  Front Neurosci       Date:  2020-07-08       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.